AMPK |
5’-Adenosine Monophosphate-activated Protein Kinase |
Akt |
Protein Kinase B |
AGEs |
Advanced Glycation End Products |
Ang |
Angiotensin II |
ARBs |
Angiotensin Receptor Blockers |
ARE |
Antioxidant response element |
BMI |
Body Mass Index |
CRP |
C-Reactive Protein |
DM |
Diabetes Mellitus |
DPP4i |
Dipeptidyl-Peptidase-4 inhibitors |
ERK |
Extracellular-signal-regulated Kinase |
eNOS |
Endothelial Nitric Oxide Synthase |
ET-1 |
Endothelin 1 |
FOXO1 |
Forkhead Box O1 |
GABA |
Gamma-Aminobutyric acid |
GLP-1 RA |
Glucagon-like Peptide-1 Receptor Agonists |
GLUT-4 |
Glucose Transporter 4 |
hCRP |
High-Sensitivity CRP |
HMGB 1 |
High Mobility Group Box chromosomal protein 1 |
IRS |
Insulin Receptor Substrate |
ICAM1 |
Intercellular Adhesion Molecule 1 |
IL-1β |
Interleukin-1Beta |
IL-6 |
Interleukin-6 |
JNK |
C-Jun N-terminal Kinase |
KLF2 |
Krüppel-Like Factor 2 |
KLF4 |
Krüppel-Like Factor 4 |
mTOR |
Mammalian Target of Rapamycin |
MAPK |
Mitogen-Activated Protein Kinase |
MCP1 |
Monocyte Chemoattractant Protein 1 |
miRNAs |
MicroRNAs |
NADPH |
Nicotinamide Adenine Dinucleotide Phosphate |
NF-κB |
Nuclear Factor-KappaB |
NO |
Nitric Oxide |
NOX |
NADPH Oxidase |
Nrf2 |
E2-related factor 2 |
PDE-5i |
Phosphodiesterase-5 inhibitors |
PET-CT |
Positron emission tomography—computed tomography |
PI3K |
Phosphatidylinositol 3 Kinase |
PKC |
Protein Kinase C |
ROS |
Reactive Oxygen Species |
RAGE |
Receptor for AGEs |
SGLT2i |
Sodium Glucose Cotransporter 2 inhibitors |
SIRT1 |
Sirtuin 1 |
TXA2 |
Thromboxane A2 |
TNF-α |
Tumour Necrosis Factor-A |
VCAM1 |
Vascular Cell Adhesion Molecule 1 |
VEGF |
Vascular Endothelial Growth Factor |
VSMCs |
Vascular Smooth Muscle Cells |